Matthew T. Martin

Matthew T. Martin

Auto-generated profile, based on publicly available information

Matthew T. Martin

National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2006 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
DDDavid J. Dix
David J. Dix
KHKeith A. Houck
Keith A. Houck
MMMatthew T. Martin
Matthew T. Martin
ARAnn M. Richard
Ann M. Richard
RSR. Woodrow Setzer
R. Woodrow Setzer
RKRobert J. Kavlock
Robert J. Kavlock
The U.S. Environmental Protection Agency (EPA) is developing methods for utilizing computational chemistry, high-throughput screening (HTS), and various toxicogenomic technologies to predict potential for toxicity and prioritize limited testing resources toward chemicals that likely represent the greatest hazard to human health and the environment. This chemical prioritization research program, entitled “ToxCast,” is being initiated with the purpose of developing the ability to forecast toxicity based on bioactivity profiling. The proof-of-concept phase of ToxCast will focus upon chemicals with an existing, rich toxicological database in order to provide an interpretive context for the ToxCast data. This set of several hundred reference chemicals will represent numerous structural classes and phenotypic outcomes, including tumorigens, developmental and reproductive toxicants, neurotoxicants, and immunotoxicants. The ToxCast program will evaluate chemical properties and bioactivity profiles across a broad spectrum of data domains: physical-chemical, predicted biological activities based on existing structure-activity models, biochemical properties based on HTS assays, cell-based phenotypic assays, and genomic and metabolomic analyses of cells. These data will be generated through a series of external contracts, along with collaborations across EPA, with the National Toxicology Program, and with the National Institutes of Health Chemical Genomics Center. The resulting multidimensional data set provides an informatics challenge requiring appropriate computational methods for integrating various chemical, biological, and toxicological data into profiles and models predicting toxicity.

1 April 2010 in Environmental Health Perspectives
Verified
Journal Article
Open access
RJRichard Judson
Richard Judson
KHKeith A. Houck
Keith A. Houck
RKRobert J. Kavlock
Robert J. Kavlock
TKThomas B. Knudsen
Thomas B. Knudsen
MMMatthew T. Martin
Matthew T. Martin
DDDavid J. Dix
David J. Dix
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences

15 May 2012 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
RKRobert Kavlock
Robert Kavlock
KCKelly Chandler
Kelly Chandler
KHKeith Houck
Keith Houck
SHSid Hunter
Sid Hunter
RJRichard Judson
Richard Judson
DDDavid Dix
David Dix

1 December 2010 in Environmental Health Perspectives
Verified
Journal Article
Open access
David ReifDavid Reif
David Reif
MMMatthew T. Martin
Matthew T. Martin
STShirlee W. Tan
Shirlee W. Tan
KHKeith A. Houck
Keith A. Houck
RJRichard Judson
Richard Judson
RKRobert J. Kavlock
Robert J. Kavlock
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences

16 July 2010 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
DRDaniel Rotroff
Daniel Rotroff
BWBarbara A. Wetmore
Barbara A. Wetmore
DDDavid J. Dix
David J. Dix
SFStephen S. Ferguson
Stephen S. Ferguson
HCHarvey J. Clewell
Harvey J. Clewell
RTRussell S. Thomas
Russell S. Thomas
Many chemicals in commerce today have undergone limited or no safety testing. To reduce the number of untested chemicals and prioritize limited testing resources, several governmental programs are using high-throughput in vitro screens for assessing chemical effects across multiple cellular pathways. In this study, metabolic clearance and plasma protein binding were experimentally measured for 35 ToxCast phase I chemicals. The experimental data were used to parameterize a population-based in vitro-to-in vivo extrapolation model for estimating the human oral equivalent dose necessary to produce a steady-state in vivo concentration equivalent to in vitro AC50 (concentration at 50% of maximum activity) and LEC (lowest effective concentration) values from the ToxCast data. For 23 of the 35 chemicals, the range of oral equivalent doses for up to 398 ToxCast assays was compared with chronic aggregate human oral exposure estimates in order to assess whether significant in vitro bioactivity occurred within the range of maximum expected human oral exposure. Only 2 of the 35 chemicals, triclosan and pyrithiobac-sodium, had overlapping oral equivalent doses and estimated human oral exposures. Ranking by the potencies of the AC50 and LEC values, these two chemicals would not have been at the top of a prioritization list. Integrating both dosimetry and human exposure information with the high-throughput toxicity screening efforts provides a better basis for making informed decisions on chemical testing priorities and regulatory attention. Importantly, these tools are necessary to move beyond hazard rankings to estimates of possible in vivo responses based on in vitro screens.

22 November 2016 in Bioinformatics
Verified
Journal Article
Open access
PDF file
DFDayne L Filer
Dayne L Filer
PKParth Kothiya
Parth Kothiya
RSR Woodrow Setzer
R Woodrow Setzer
RJRichard S Judson
Richard S Judson
MMMatthew T Martin
Matthew T Martin
Motivation: Large high-throughput screening (HTS) efforts are widely used in drug development and chemical toxicity screening. Wide use and integration of these data can benefit from an efficient, transparent, and reproducible data pipeline.